BODY ACTION PRODUCTS Prolong Lubricating

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: BODY ACTION PRODUCTS Prolong Lubricating
Generic name: BENZOCAINE
Manufacturer: PRODUCT MAX GROUP INC
Product type: HUMAN OTC DRUG
SPL set ID: 3bef5915-1c98-4011-baa9-ad0bbef200c2
SPL ID: 09d769cf-cc49-9fd3-e063-6394a90ac18e
Version: 2
Effective date: 2023-11-10
Source export date: 2026-10-30
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/0b630a6825fc0c8abba22d7c8fd4d069bde78bef928766047ddbb369119f337f/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 19:02:30

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M015	openfda.application_number
brand name		BODY ACTION PRODUCTS Prolong Lubricating	openfda.brand_name
generic name		BENZOCAINE	openfda.generic_name
manufacturer name		PRODUCT MAX GROUP INC	openfda.manufacturer_name
ndc	package	70742-288-00	openfda.package_ndc
ndc	product	70742-288	openfda.product_ndc
ndc11	package	70742028800	derived:openfda.package_ndc
spl id		09d769cf-cc49-9fd3-e063-6394a90ac18e	id
spl set id		3bef5915-1c98-4011-baa9-ad0bbef200c2	set_id
unii		U3RSY48JW5	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Avoid contact with the eyes. Premature ejaculation may be due to a condition requiring medical supervision. If this product, used as directed, does not provide relief, discontinue use and consult a doctor. If you or your partner develop a rash or irritation, such as burning or itching, discontinue use. If symptoms persist, consult a doctor. Keep out of reach of children. If swallowed get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.